Benign Prostatic Hyperplasia Surgical Treatment Market OverviewThe global benign prostatic hyperplasia surgical treatment ...

Benign Prostatic Hyperplasia (BPH), or prostate enlargement, is a common condition affecting aging men in India. It often ...

PROCEPT BioRobotics’ model fair value sits at US$30.44 per share, with no change to the central price target despite refreshed assumptions. That steady target comes as analysts split between focusing ...

Accord Healthcare, Inc., a leading generic pharmaceutical company, committed to improving access to affordable medicines, today announced the relaunch of Tadalafil Tablets, an FDA-approved ...

Storage symptoms favored the OAB group, despite comparable overall symptom improvement for those with, without OAB.

Learn how to take care of your prostate in your 30s, 40s and beyond, including symptoms to watch for and ways to reduce your ...

Sonablate, a medical technology company focused on non-invasive prostate cancer treatment using high-intensity focused ultrasound (HIFU) , today announced the appointment of Brad Saar, former ...

With a street-high upside potential of 109.4%, PROCEPT BioRobotics Corporation (NASDAQ:PRCT) ranks among the 10 best robotics ...

Prostate health is a lifelong concern for men, with risks increasing significantly after age 40. From benign enlargement to prostate cancer, early awareness, healthy habits, and timely screenings can ...

ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. VANCOUVER, BC, April 29, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary – There's a quiet bidding war underway for AI diagnostics, and the price ...

PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the 'Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported ...

King Charles III was diagnosed with a 'form of cancer' in 2024 and is still carrying on with royal duties. Find out more ...